Ascorbic acid-modified brain-specific liposomes drug delivery system with “lock-in” function
作者:Wenjiao Xiao、Qiuyi Fu、Yi Zhao、Li Zhang、Qiming Yue、Li Hai、Li Guo、Yong Wu
DOI:10.1016/j.chemphyslip.2019.01.005
日期:2019.11
In this study, a novel brain targeting ascorbic acid (AA) derivative with “lock-in” function was designed and synthesized as a liposome ligand to prepare novel liposomes to achieve the effective delivery of drug formulations to brain via glucose transporter 1 (GLUT1) and the Na+-dependent vitamin C transporter (SVCT2). The liposome was prepared and characterized in terms of the particle size, zeta
在这项研究中,设计并合成了具有“锁定”功能的新型脑靶向抗坏血酸(AA)衍生物作为脂质体配体,以制备新型脂质体,以实现药物制剂通过葡萄糖转运蛋白1(GLUT 1)的有效递送。)和依赖Na +的维生素C转运蛋白(SVCT 2)。制备脂质体并根据粒径,ζ电势,包封效率,释放曲线,稳定性,溶血性和细胞毒性来表征。体内初步评估证明了与裸紫杉萜,未包被的和AA包被的脂质体相比,AA-硫胺素二硫化物系统(TDS)包被的脂质体具有改善的靶向能力,并显着增加了多西他赛(DTX)的脑部浓度。与裸紫杉萜相比,相对吸收效率和浓缩效率分别提高了3.24倍和5.62倍。分布数据和药代动力学参数均表明抗坏血酸硫胺素二硫化物输送系统是增强中枢神经系统(CNS)药物向大脑输送能力的有前途的载体。